nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Erectile dysfunction—Lovastatin—atherosclerosis	0.0121	0.0215	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Ezetimibe—atherosclerosis	0.0119	0.0211	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Niacin—atherosclerosis	0.0113	0.0202	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Simvastatin—atherosclerosis	0.0113	0.0201	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Pravastatin—atherosclerosis	0.0112	0.0199	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Niacin—atherosclerosis	0.0104	0.0185	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Pravastatin—atherosclerosis	0.0102	0.0182	CcSEcCtD
Methylscopolamine bromide—Confusional state—Rosuvastatin—atherosclerosis	0.00888	0.0158	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Lovastatin—atherosclerosis	0.00862	0.0153	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Simvastatin—atherosclerosis	0.00806	0.0143	CcSEcCtD
Methylscopolamine bromide—Insomnia—Rosuvastatin—atherosclerosis	0.00796	0.0142	CcSEcCtD
Methylscopolamine bromide—Palpitations—Ezetimibe—atherosclerosis	0.00792	0.0141	CcSEcCtD
Methylscopolamine bromide—Tension—Niacin—atherosclerosis	0.00771	0.0137	CcSEcCtD
Methylscopolamine bromide—Nervousness—Niacin—atherosclerosis	0.00763	0.0136	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Lovastatin—atherosclerosis	0.00761	0.0135	CcSEcCtD
Methylscopolamine bromide—Tension—Pravastatin—atherosclerosis	0.00759	0.0135	CcSEcCtD
Methylscopolamine bromide—Constipation—Rosuvastatin—atherosclerosis	0.00753	0.0134	CcSEcCtD
Methylscopolamine bromide—Confusional state—Lovastatin—atherosclerosis	0.00752	0.0134	CcSEcCtD
Methylscopolamine bromide—Nervousness—Pravastatin—atherosclerosis	0.00751	0.0134	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Ezetimibe—atherosclerosis	0.00747	0.0133	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Lovastatin—atherosclerosis	0.00746	0.0133	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Niacin—atherosclerosis	0.0074	0.0132	CcSEcCtD
Methylscopolamine bromide—Confusional state—Ezetimibe—atherosclerosis	0.00738	0.0131	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00732	0.013	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Pravastatin—atherosclerosis	0.00729	0.013	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00726	0.0129	CcSEcCtD
Methylscopolamine bromide—Confusional state—Simvastatin—atherosclerosis	0.00704	0.0125	CcSEcCtD
Methylscopolamine bromide—Urticaria—Rosuvastatin—atherosclerosis	0.00699	0.0124	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Simvastatin—atherosclerosis	0.00698	0.0124	CcSEcCtD
Methylscopolamine bromide—Palpitations—Niacin—atherosclerosis	0.00694	0.0123	CcSEcCtD
Methylscopolamine bromide—Insomnia—Lovastatin—atherosclerosis	0.00675	0.012	CcSEcCtD
Methylscopolamine bromide—Insomnia—Ezetimibe—atherosclerosis	0.00662	0.0118	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Niacin—atherosclerosis	0.00654	0.0116	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00649	0.0115	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Niacin—atherosclerosis	0.00641	0.0114	CcSEcCtD
Methylscopolamine bromide—Constipation—Lovastatin—atherosclerosis	0.00638	0.0114	CcSEcCtD
Methylscopolamine bromide—Confusional state—Pravastatin—atherosclerosis	0.00636	0.0113	CcSEcCtD
Methylscopolamine bromide—Asthenia—Rosuvastatin—atherosclerosis	0.00632	0.0112	CcSEcCtD
Methylscopolamine bromide—Insomnia—Simvastatin—atherosclerosis	0.00631	0.0112	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Pravastatin—atherosclerosis	0.00631	0.0112	CcSEcCtD
Methylscopolamine bromide—Constipation—Ezetimibe—atherosclerosis	0.00626	0.0111	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Niacin—atherosclerosis	0.00625	0.0111	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Lovastatin—atherosclerosis	0.00615	0.0109	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Ezetimibe—atherosclerosis	0.00603	0.0107	CcSEcCtD
Methylscopolamine bromide—Constipation—Simvastatin—atherosclerosis	0.00597	0.0106	CcSEcCtD
Methylscopolamine bromide—Urticaria—Lovastatin—atherosclerosis	0.00593	0.0105	CcSEcCtD
Methylscopolamine bromide—Dizziness—Rosuvastatin—atherosclerosis	0.00582	0.0104	CcSEcCtD
Methylscopolamine bromide—Urticaria—Ezetimibe—atherosclerosis	0.00581	0.0103	CcSEcCtD
Methylscopolamine bromide—Insomnia—Niacin—atherosclerosis	0.0058	0.0103	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Simvastatin—atherosclerosis	0.00575	0.0102	CcSEcCtD
Methylscopolamine bromide—Insomnia—Pravastatin—atherosclerosis	0.00571	0.0102	CcSEcCtD
Methylscopolamine bromide—Somnolence—Niacin—atherosclerosis	0.0057	0.0101	CcSEcCtD
Methylscopolamine bromide—Urticaria—Simvastatin—atherosclerosis	0.00554	0.00987	CcSEcCtD
Methylscopolamine bromide—Headache—Rosuvastatin—atherosclerosis	0.00552	0.00981	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Lovastatin—atherosclerosis	0.0055	0.00978	CcSEcCtD
Methylscopolamine bromide—Constipation—Pravastatin—atherosclerosis	0.0054	0.0096	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Ezetimibe—atherosclerosis	0.00539	0.00959	CcSEcCtD
Methylscopolamine bromide—Asthenia—Lovastatin—atherosclerosis	0.00535	0.00953	CcSEcCtD
Methylscopolamine bromide—Asthenia—Ezetimibe—atherosclerosis	0.00525	0.00934	CcSEcCtD
Methylscopolamine bromide—Nausea—Rosuvastatin—atherosclerosis	0.00523	0.00931	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Pravastatin—atherosclerosis	0.0052	0.00925	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Simvastatin—atherosclerosis	0.00514	0.00915	CcSEcCtD
Methylscopolamine bromide—Urticaria—Niacin—atherosclerosis	0.00509	0.00906	CcSEcCtD
Methylscopolamine bromide—Urticaria—Pravastatin—atherosclerosis	0.00501	0.00892	CcSEcCtD
Methylscopolamine bromide—Asthenia—Simvastatin—atherosclerosis	0.00501	0.00891	CcSEcCtD
Methylscopolamine bromide—Dizziness—Lovastatin—atherosclerosis	0.00493	0.00878	CcSEcCtD
Methylscopolamine bromide—Dizziness—Ezetimibe—atherosclerosis	0.00484	0.00861	CcSEcCtD
Methylscopolamine bromide—Vomiting—Lovastatin—atherosclerosis	0.00474	0.00844	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Niacin—atherosclerosis	0.00472	0.0084	CcSEcCtD
Methylscopolamine bromide—Headache—Lovastatin—atherosclerosis	0.00467	0.00832	CcSEcCtD
Methylscopolamine bromide—Vomiting—Ezetimibe—atherosclerosis	0.00465	0.00828	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Pravastatin—atherosclerosis	0.00465	0.00827	CcSEcCtD
Methylscopolamine bromide—Dizziness—Simvastatin—atherosclerosis	0.00462	0.00821	CcSEcCtD
Methylscopolamine bromide—Asthenia—Niacin—atherosclerosis	0.0046	0.00818	CcSEcCtD
Methylscopolamine bromide—Headache—Ezetimibe—atherosclerosis	0.00458	0.00816	CcSEcCtD
Methylscopolamine bromide—Asthenia—Pravastatin—atherosclerosis	0.00453	0.00806	CcSEcCtD
Methylscopolamine bromide—Vomiting—Simvastatin—atherosclerosis	0.00444	0.0079	CcSEcCtD
Methylscopolamine bromide—Nausea—Lovastatin—atherosclerosis	0.00443	0.00789	CcSEcCtD
Methylscopolamine bromide—Headache—Simvastatin—atherosclerosis	0.00437	0.00778	CcSEcCtD
Methylscopolamine bromide—Nausea—Ezetimibe—atherosclerosis	0.00435	0.00773	CcSEcCtD
Methylscopolamine bromide—Dizziness—Niacin—atherosclerosis	0.00424	0.00754	CcSEcCtD
Methylscopolamine bromide—Dizziness—Pravastatin—atherosclerosis	0.00417	0.00742	CcSEcCtD
Methylscopolamine bromide—Nausea—Simvastatin—atherosclerosis	0.00415	0.00738	CcSEcCtD
Methylscopolamine bromide—Vomiting—Niacin—atherosclerosis	0.00407	0.00725	CcSEcCtD
Methylscopolamine bromide—Headache—Niacin—atherosclerosis	0.00401	0.00714	CcSEcCtD
Methylscopolamine bromide—Vomiting—Pravastatin—atherosclerosis	0.00401	0.00714	CcSEcCtD
Methylscopolamine bromide—Headache—Pravastatin—atherosclerosis	0.00395	0.00703	CcSEcCtD
Methylscopolamine bromide—Nausea—Niacin—atherosclerosis	0.00381	0.00677	CcSEcCtD
Methylscopolamine bromide—Nausea—Pravastatin—atherosclerosis	0.00375	0.00667	CcSEcCtD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000196	0.000449	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AGTR1—atherosclerosis	0.000196	0.000447	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	0.000196	0.000447	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	0.000195	0.000446	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.000194	0.000443	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—HMGCR—atherosclerosis	0.000193	0.000442	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL2—atherosclerosis	0.000192	0.000439	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PLG—atherosclerosis	0.000191	0.000436	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000187	0.000426	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	0.000186	0.000425	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VWF—atherosclerosis	0.000186	0.000425	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VWF—atherosclerosis	0.000185	0.000423	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOC3—atherosclerosis	0.000185	0.000422	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.000184	0.000421	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOC3—atherosclerosis	0.000184	0.000421	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LDLR—atherosclerosis	0.000184	0.000419	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.000184	0.000419	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LDLR—atherosclerosis	0.000183	0.000418	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.000182	0.000417	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000181	0.000414	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000181	0.000413	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SOCS3—atherosclerosis	0.000181	0.000413	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	0.00018	0.000412	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL3—atherosclerosis	0.000179	0.00041	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL3—atherosclerosis	0.000179	0.000408	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.000179	0.000408	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000177	0.000404	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP3—atherosclerosis	0.000175	0.000399	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF2—atherosclerosis	0.000174	0.000397	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ABCA1—atherosclerosis	0.000172	0.000394	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NCF1—atherosclerosis	0.000172	0.000392	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NCF1—atherosclerosis	0.000171	0.000391	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NCF1—atherosclerosis	0.00017	0.000387	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOB—atherosclerosis	0.000169	0.000385	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCL8—atherosclerosis	0.000167	0.000382	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—F2—atherosclerosis	0.000167	0.000382	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—F2—atherosclerosis	0.000167	0.000381	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EDN1—atherosclerosis	0.000166	0.000379	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—F2—atherosclerosis	0.000165	0.000377	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL5—atherosclerosis	0.000165	0.000376	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AGT—atherosclerosis	0.000164	0.000375	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AGT—atherosclerosis	0.000164	0.000374	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR2—atherosclerosis	0.000162	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000162	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.000162	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.000162	0.000369	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.000162	0.000369	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.000162	0.000369	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LPL—atherosclerosis	0.000161	0.000368	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.000161	0.000368	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.00016	0.000366	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.00016	0.000366	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00016	0.000365	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00016	0.000364	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000159	0.000364	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.000158	0.000361	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.000158	0.000361	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.000158	0.000361	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000158	0.000361	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000158	0.00036	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000158	0.00036	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000158	0.00036	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PRKCG—atherosclerosis	0.000157	0.000358	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000156	0.000356	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000156	0.000356	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000156	0.000356	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SPP1—atherosclerosis	0.000153	0.000349	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCL8—atherosclerosis	0.000152	0.000347	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.000152	0.000347	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000151	0.000346	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.00015	0.000342	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—HMOX1—atherosclerosis	0.000148	0.000338	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000145	0.000332	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	0.000145	0.000331	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000143	0.000328	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOB—atherosclerosis	0.000142	0.000323	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PDGFB—atherosclerosis	0.000141	0.000322	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KNG1—atherosclerosis	0.000139	0.000317	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KNG1—atherosclerosis	0.000138	0.000316	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000138	0.000315	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AGT—atherosclerosis	0.000138	0.000315	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GSTM1—atherosclerosis	0.000138	0.000315	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	0.000138	0.000314	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KNG1—atherosclerosis	0.000137	0.000313	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	0.000136	0.000311	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000135	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—LPL—atherosclerosis	0.000135	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LEP—atherosclerosis	0.000135	0.000308	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOE—atherosclerosis	0.000135	0.000308	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	0.000135	0.000308	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PLG—atherosclerosis	0.000134	0.000307	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PLG—atherosclerosis	0.000134	0.000306	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CAV1—atherosclerosis	0.000134	0.000306	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	0.000134	0.000305	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOA1—atherosclerosis	0.000134	0.000305	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PLG—atherosclerosis	0.000133	0.000303	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GPX1—atherosclerosis	0.000132	0.000301	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ESR1—atherosclerosis	0.000129	0.000294	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CD36—atherosclerosis	0.000129	0.000293	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—F2—atherosclerosis	0.000127	0.000291	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000127	0.000291	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	0.000127	0.00029	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	0.000126	0.000287	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP3—atherosclerosis	0.000123	0.000281	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP3—atherosclerosis	0.000123	0.00028	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF2—atherosclerosis	0.000122	0.00028	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF2—atherosclerosis	0.000122	0.000279	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	0.000122	0.000278	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MTHFR—atherosclerosis	0.000122	0.000278	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP3—atherosclerosis	0.000121	0.000277	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF2—atherosclerosis	0.000121	0.000276	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARA—atherosclerosis	0.000119	0.000273	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOB—atherosclerosis	0.000119	0.000271	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOB—atherosclerosis	0.000118	0.00027	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000118	0.000269	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000117	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOB—atherosclerosis	0.000117	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EDN1—atherosclerosis	0.000117	0.000267	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	0.000117	0.000267	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EDN1—atherosclerosis	0.000117	0.000266	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000116	0.000266	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL5—atherosclerosis	0.000116	0.000265	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AGT—atherosclerosis	0.000116	0.000264	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL5—atherosclerosis	0.000116	0.000264	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EDN1—atherosclerosis	0.000115	0.000264	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—INS—atherosclerosis	0.000115	0.000264	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL5—atherosclerosis	0.000115	0.000262	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL2—atherosclerosis	0.000114	0.000259	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LPL—atherosclerosis	0.000113	0.000259	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—atherosclerosis	0.000113	0.000259	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LPL—atherosclerosis	0.000113	0.000258	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CAV1—atherosclerosis	0.000112	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOA1—atherosclerosis	0.000112	0.000256	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LPL—atherosclerosis	0.000112	0.000256	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1—atherosclerosis	0.000112	0.000255	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	0.00011	0.000252	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	0.00011	0.000251	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	0.000109	0.000249	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SPP1—atherosclerosis	0.000107	0.000245	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SPP1—atherosclerosis	0.000107	0.000245	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	0.000107	0.000244	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	0.000107	0.000244	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SPP1—atherosclerosis	0.000106	0.000242	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	0.000106	0.000242	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	0.000106	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CG—atherosclerosis	0.000102	0.000234	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOS3—atherosclerosis	0.000101	0.000231	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	9.94e-05	0.000227	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	9.91e-05	0.000226	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARG—atherosclerosis	9.88e-05	0.000226	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	9.82e-05	0.000224	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGT—atherosclerosis	9.71e-05	0.000222	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—INS—atherosclerosis	9.69e-05	0.000221	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGT—atherosclerosis	9.68e-05	0.000221	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGT—atherosclerosis	9.58e-05	0.000219	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LEP—atherosclerosis	9.51e-05	0.000217	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—atherosclerosis	9.51e-05	0.000217	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LEP—atherosclerosis	9.48e-05	0.000216	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—atherosclerosis	9.48e-05	0.000216	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CAV1—atherosclerosis	9.42e-05	0.000215	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOA1—atherosclerosis	9.4e-05	0.000215	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CAV1—atherosclerosis	9.39e-05	0.000214	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—atherosclerosis	9.39e-05	0.000214	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LEP—atherosclerosis	9.39e-05	0.000214	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOA1—atherosclerosis	9.37e-05	0.000214	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CAV1—atherosclerosis	9.3e-05	0.000212	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOA1—atherosclerosis	9.28e-05	0.000212	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ESR1—atherosclerosis	9.08e-05	0.000207	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ESR1—atherosclerosis	9.05e-05	0.000207	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	8.98e-05	0.000205	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—F2—atherosclerosis	8.97e-05	0.000205	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ESR1—atherosclerosis	8.96e-05	0.000205	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—F2—atherosclerosis	8.94e-05	0.000204	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—atherosclerosis	8.88e-05	0.000203	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—F2—atherosclerosis	8.85e-05	0.000202	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	8.67e-05	0.000198	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	8.58e-05	0.000196	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	8.56e-05	0.000195	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—atherosclerosis	8.54e-05	0.000195	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NOS3—atherosclerosis	8.49e-05	0.000194	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	8.47e-05	0.000193	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	8.22e-05	0.000188	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	8.19e-05	0.000187	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—INS—atherosclerosis	8.13e-05	0.000186	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—atherosclerosis	8.12e-05	0.000185	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	8.12e-05	0.000185	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—INS—atherosclerosis	8.1e-05	0.000185	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	8.03e-05	0.000183	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—INS—atherosclerosis	8.02e-05	0.000183	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—atherosclerosis	7.99e-05	0.000183	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—atherosclerosis	7.97e-05	0.000182	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	7.9e-05	0.00018	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—atherosclerosis	7.89e-05	0.00018	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	7.88e-05	0.00018	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1—atherosclerosis	7.86e-05	0.000179	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1—atherosclerosis	7.83e-05	0.000179	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—atherosclerosis	7.77e-05	0.000177	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1—atherosclerosis	7.76e-05	0.000177	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	7.46e-05	0.00017	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	7.44e-05	0.00017	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	7.37e-05	0.000168	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	7.29e-05	0.000166	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT3—atherosclerosis	7.22e-05	0.000165	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOS3—atherosclerosis	7.13e-05	0.000163	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOS3—atherosclerosis	7.1e-05	0.000162	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOS3—atherosclerosis	7.03e-05	0.000161	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	6.9e-05	0.000157	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	6.69e-05	0.000153	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	6.32e-05	0.000144	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	6.3e-05	0.000144	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	6.24e-05	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	6.11e-05	0.000139	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	6.09e-05	0.000139	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	6.03e-05	0.000138	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—atherosclerosis	6.01e-05	0.000137	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—atherosclerosis	5.99e-05	0.000137	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—atherosclerosis	5.93e-05	0.000135	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—atherosclerosis	5.72e-05	0.000131	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—atherosclerosis	5.7e-05	0.00013	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	5.66e-05	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—atherosclerosis	5.64e-05	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	5.64e-05	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	5.58e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	5.56e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	5.54e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	5.54e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	5.53e-05	0.000126	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	5.49e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	5.47e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	5.13e-05	0.000117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	5.12e-05	0.000117	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT3—atherosclerosis	5.08e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	5.07e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT3—atherosclerosis	5.07e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—atherosclerosis	5.04e-05	0.000115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT3—atherosclerosis	5.02e-05	0.000115	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	4.86e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	4.84e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	4.79e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	4.71e-05	0.000108	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	4.7e-05	0.000107	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—atherosclerosis	4.65e-05	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	4.65e-05	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—atherosclerosis	3.9e-05	8.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—atherosclerosis	3.55e-05	8.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—atherosclerosis	3.54e-05	8.08e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—atherosclerosis	3.5e-05	8e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—atherosclerosis	3.28e-05	7.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—atherosclerosis	3.27e-05	7.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—atherosclerosis	3.23e-05	7.38e-05	CbGpPWpGaD
